Both in Ophthalmic Goods
RxSight vs Bausch + Lomb
Over the past year RXST returned −47.1% and BLCO returned +31.3%; their daily moves had a correlation of 0.32.
RXST −47.1% BLCO +31.3%Growth of $1, one year, split-adjusted
| Metric | RXST | BLCO |
|---|---|---|
| Price | $4.59 | $20.03 |
| Market cap | $190.9M | $7.16B |
| Today | −4.38% | +0.10% |
| 1 month | −3.6% | +16.7% |
| 6 months | −36.8% | +25.2% |
| Year to date | −56.0% | +17.3% |
| 1 year | −47.8% | +34.1% |
| Revenue growth (YoY) | +0.3% | +7.3% |
| Gross margin | 76.7% | 64.7% |
| Net margin | −35.9% | 2.3% |
| P/E (TTM) | — | — |
| Price / sales | 1.5× | 1.3× |
| Net cash | $208.8M | -$4.58B |
| Dividend yield | — | — |
| Volatility (60d) | 49.8% | 38.8% |
| Short % of float | 10.5% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).